Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 2172-2175, 2006; 10.1373/clinchem.2006.072850
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 072850.Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nalefski, E. A.
Right arrow Articles by Whitney, D. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nalefski, E. A.
Right arrow Articles by Whitney, D. H.
Related Collections
Right arrow Oak Ridge Conference
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2006;52:2172-2175.)
© 2006 American Association for Clinical Chemistry, Inc.


Abstracts of Oak Ridge Posters

Single-Molecule Detection for Femtomolar Quantification of Proteins in Heterogeneous Immunoassays

Eric A. Nalefski, Christina M. D’Antoni, Evan P. Ferrell, Janice A. Lloyd, Haoqun Qiu, John L. Harris and Duncan H. Whitneya

(U.S. Genomics, Woburn, MA;

aaddress correspondence to this author at: U.S. Genomics, 12 Gill St., Suite 4700, Woburn, MA 01801; fax 781-938-0060, e-mail dwhitney@usgenomics.com)

The first 300 words of the full text of this article appear below.

There is growing interest in the development of ultrasensitive immunoassays to facilitate validation of novel biomarkers, especially serum biomarkers, and the application of those assays in clinical settings (1). Current assays focus predominantly on abundantly produced protein biomarkers, such as cardiovascular structural proteins that leak into the bloodstream, and less so on lower abundance cytokines and chemokines (2). Even rarer markers, such as those released from cancerous cells into the bloodstream, remain more elusive (3). Approaches that exploit recent technological advances in molecular imaging, especially at the single-molecule level (4), are likely to improve the detection limits of the immunoassay, and therefore enable improved detection of these markers.

Microfluidic sample delivery and confocal microscopic detection of labeled biomolecules are useful for detecting targets of interest (5)(6). Two-color correlation counting derived from focused laser-induced excitation allows for high signal-to-noise detection even in the presence of large excesses of free probes, enabling measurement of single molecular events (6). Flow velocity and data acquisition rates can be matched to provide highly accurate quantification, even for rapid analyses on the order of seconds per sample, and analysis time can easily be extended to provide increased detection efficiency of rare targets.

Development and application of new assays are straightforward processes based on well-understood fluorescence methods. We describe application of the Trilogy® 2020 Single Molecule Analyzer for analysis of heterogeneous immunoassays. The human gonadotropin follicle-stimulating hormone (FSH), which plays a central role in fertility (7), was chosen as a representative analyte because of its clinical importance and current clinical requirements for high-sensitivity detection (8).

The Trilogy 2020 instrument uses laser beams shaped into stripes for fluorescence illumination and focuses the beams through a microscope objective into the center . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
H. Qiu, E. P. Ferrell, N. Nolan, B. H. Phelps, R. Tabibiazar, D. H. Whitney, and E. A. Nalefski
Fluorescence single-molecule counting assays for high-sensitivity detection of cytokines and chemokines.
Clin. Chem., November 1, 2007; 53(11): 2010 - 2012.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.